We use cookies for a better user experience. Read our Privacy Policy

I Agree

Ultrasonic Nebulizers Market

Ultrasonic Nebulizers Market (Size: Small-volume Ultrasonic Nebulizer and Large-volume Ultrasonic Nebulizer; and Application: COPD, Asthma, Cystic Fibrosis, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Ultrasonic Nebulizers Market Outlook 2031

  • The global industry was valued at US$ 197.3 Mn in 2021
  • It is projected to grow at a CAGR of 5.4% from 2022 to 2031 and reach more than US$ 325.6 Mn by the end of 2031

Analysts’ Viewpoint

Rise in prevalence of respiratory diseases is expected to drive global ultrasonic nebulizers market size during the forecast period. Nebulizer is used to deliver medication directly to the lungs. Increase in consumer awareness about the benefits of home healthcare and availability of insurance coverage for respiratory conditions are anticipated to fuel market expansion. Growth in demand for portable nebulizers and technological advancements in ultrasonic nebulization technology are estimated to accelerate market development in the next few years.

Research and development of new technologies is likely to offer lucrative opportunities for vendors in the industry. Key players are launching advanced nebulizers in order to increase their ultrasonic nebulizers market share.

Ultrasonic Nebulizers Market

Ultrasonic Nebulizers Market Introduction

Ultrasonic nebulizer machines are devices that convert liquid medication into a fine mist, allowing it to be inhaled into the lungs. These devices are commonly used to treat respiratory conditions such as asthma and Chronic Obstructive Pulmonary Disease (COPD).

The mist created by the ultrasonic nebulizer is easily inhaled and deposited deep into the lungs, providing fast and effective relief from respiratory symptoms. Small-volume ultrasonic nebulizer and large-volume ultrasonic nebulizer are the two types of ultrasonic nebulizer.

Request a sample to get extensive insights into the Ultrasonic Nebulizers Market

Rise in Prevalence of Respiratory Disorders

The global ultrasonic nebulizer market is expected to be driven by the surge in prevalence of respiratory disorders such as asthma, COPD, and cystic fibrosis. Recent technological advancements have made nebulizers more portable and patient-friendly. Furthermore, various types of medications are widely available in nebulized formulations, enabling people with COPD, asthma, and other conditions to use nebulizers outside of acute care settings, such as clinics and hospitals.

According to the World Health Organization (WHO), around 235 million people had asthma across the globe, while an estimated 384 million people suffered from COPD, in 2021. The prevalence of cystic fibrosis is increasing, with around 70,000 cases reported globally in 2021.

Growth in Geriatric Population

Elderly people are more susceptible to respiratory disorders. Hence, demand for ultrasonic inhaler nebulizers is projected to increase among the geriatric population. According to the United Nations, the global population aged 60 years or above is likely to rise from 962 million in 2017 to 2.1 billion by 2050.

Prevalence of chronic respiratory diseases increases with age, and older adults are more likely to develop these conditions. Growth in demand for ultrasonic nebulizer among the elderly population is expected to fuel market progress.

Request a custom report on Ultrasonic Nebulizers Market

High Output of Medication in Short Time

In terms of size, the large-volume ultrasonic nebulizer segment held significant share of the global ultrasonic nebulizers market in 2021. Rise in prevalence of respiratory diseases such as COPD, asthma, and cystic fibrosis is anticipated to augment the segment in the next few years.

Large-volume ultrasonic nebulizers can produce high output of medication in a short period of time. These are typically used in hospitals and clinics for the treatment of respiratory disorders. The large-volume ultrasonic nebulizers segment is expected to witness robust growth during the forecast period due to the increase in demand in hospitals and clinics.

Increase in Incidence of Asthma

Based on application, the asthma segment is likely to account for major share of the global ultrasonic nebulizers market during the forecast period. Asthma is a chronic respiratory condition that affects millions of people across the world. Thus, increase in incidence of asthma is driving the demand for effective treatment options.

Ultrasonic nebulizers are commonly used to deliver medication to patients with asthma, as these devices can effectively break down medication into small particles that can be easily inhaled.

Regional Outlook of Global Ultrasonic Nebulizers Market

North America held the largest share of around 40.0% of the global ultrasonic nebulizers industry in 2021. The region is projected to be a highly lucrative market during the forecast period. North America's global dominance can be ascribed to the increase in incidence of respiratory disorders such as COPD, asthma, and others in the region.

The U.S. dominated the business in North America owing to factors such as presence of prominent players and increase in research & development activities.

Asia Pacific is projected to be the fastest growing ultrasonic nebulizers market during the forecast period. The market in the region is anticipated to expand at a high CAGR from 2022 to 2031 due to high incidence rate of respiratory disorders and increase in population.

Analysis of Key Players

The global ultrasonic nebulizers market is fragmented, with the presence of large number of players. Most of the companies are investing significantly in research & development activities, primarily to introduce innovative devices. Expansion of product portfolio and merger & acquisition are the key strategies adopted by companies in the global ultrasonic nebulizers market.

Koninklijke Philips N.V., OMRON Healthcare, Inc., Drive Medical, Invacare Corporation, Medline Industries, LP, Agilent Technologies, Inc., AireHealth, Inspired Medical, Mercury Medical, and Besmed are the prominent market players.

Key Developments in Global Ultrasonic Nebulizers Market

  • In December 2020, AireHealth announced that it had received FDA 510(k) clearance for VitalMed nebulizer. The portable device is intended to nebulize liquid medications for inhalation by patients in and out of the home.
  • In July 2020, OMRON Healthcare announced the addition of OMRON NE C106, a new compressor nebulizer, to its portfolio. The device offers ease of use, affordability, durability, and suitability for all members of a family. It also ensures quick and efficient drug delivery.

Each of these players has been profiled in the ultrasonic nebulizers market report based on parameters such as company overview, strategies, portfolio, segments, and recent developments.

Global Ultrasonic Nebulizers Market Snapshot

Attribute

Detail

Size in 2021

US$ 197.3 Mn

Forecast (Value) in 2031

More than US$ 325.6 Mn

Growth Rate (CAGR)

5.4%

Forecast Period

2022–2031

Historical Data Available for

2017–2020

Quantitative Units

US$ Mn for Value

Market Analysis

It includes segment analysis as well as regional level analysis. Furthermore, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis.

Competition Landscape

  • Market share analysis by company (2021)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials

Format

Electronic (PDF) + Excel

Market Segmentation

  • Size
    • Small-volume Ultrasonic Nebulizer
    • Large-volume Ultrasonic Nebulizer
  • Application
    • COPD
    • Asthma
    • Cystic Fibrosis
    • Others
  • End-user
    • Hospitals
    • Specialty Clinics
    • Others

Regions Covered

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Countries Covered

  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • China
  • India
  • Japan
  • Australia & New Zealand

Companies Profiled

  • Koninklijke Philips N.V
  • OMRON Healthcare, Inc.
  • Drive Medical
  • Invacare Corporation
  • Medline Industries
  • Agilent Technologies, Inc.
  • Inspired Medical
  • Mercury Medical
  • Besmed
  • AireHealth

Customization Scope

Available upon request

Pricing

Available upon request

Ultrasonic Nebulizers Market

Interested in this report?
Get a FREE Brochure now!

Get Free Brochure

*Get Brochure Report (PDF) sent to your email within minutes

Frequently Asked Questions

How big was the global ultrasonic nebulizers market in 2021?

The global industry was valued at US$ 197.3 Mn in 2021

How big will it be in 2031?

It is projected to reach more than US$ 325.6 Mn by 2031

What will be the CAGR during the forecast period?

The CAGR is anticipated to be 5.4% from 2022 to 2031

What are the prominent trends that affect growth?

Rise in prevalence of respiratory disorders and increase in geriatric population

Which region will account for major share during the forecast period?

North America is likely to account for significant share from 2022 to 2031

Who are the prominent players in the sector?

Koninklijke Philips N.V., AireHealth, OMRON Healthcare, Inc., Drive Medical, Invacare Corporation, Medline Industries, LP, Agilent Technologies, Inc., Inspired Medical, Mercury Medical, and Besmed

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Ultrasonic Nebulizers Market

4. Market Overview

    4.1. Introduction

        4.1.1. Definition

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Ultrasonic Nebulizers Market Analysis and Forecast, 2017–2031

5. Key Insights

    5.1. Technological Advancements

    5.2. Disease Prevalence & Incidence Rate Globally With Key Countries

    5.3. Key Size/Brand Analysis

    5.4. COVID-19 Pandemic Impact on Industry (value chain and short/mid/long term impact)

6. Global Ultrasonic Nebulizers Market Analysis and Forecast, by Size

    6.1. Introduction & Definition

    6.2. Key Findings/Developments

    6.3. Market Value Forecast, by Size, 2017–2031

        6.3.1. Small-volume Ultrasonic Nebulizer

        6.3.2. Large-volume Ultrasonic Nebulizer

    6.4. Market Attractiveness Analysis, by Size

7. Global Ultrasonic Nebulizers Market Analysis and Forecast, by Application

    7.1. Introduction & Definition

    7.2. Key Findings/Developments

    7.3. Market Value Forecast, by Application, 2017–2031

        7.3.1. Chronic Obstructive Pulmonary Disease (COPD)

        7.3.2. Asthma

        7.3.3. Cystic Fibrosis

        7.3.4. Others

    7.4. Market Attractiveness Analysis, by Application

8. Global Ultrasonic Nebulizers Market Analysis and Forecast, by End-user

    8.1. Introduction & Definition

    8.2. Key Findings/Developments

    8.3. Market Value Forecast, by End-user, 2017–2031

        8.3.1. Hospitals

        8.3.2. Specialty Clinics

        8.3.3. Others

    8.4. Market Attractiveness Analysis, by End-user

9. Global Ultrasonic Nebulizers Market Analysis and Forecast, by Region

    9.1. Key Findings

    9.2. Market Value Forecast, by Region, 2017–2031

        9.2.1. North America

        9.2.2. Europe

        9.2.3. Asia Pacific

        9.2.4. Latin America

        9.2.5. Middle East & Africa

    9.3. Market Attractiveness Analysis, by Region

10. North America Ultrasonic Nebulizers Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

    10.2. Market Value Forecast, by Size, 2017–2031

        10.2.1. Small-volume Ultrasonic Nebulizer

        10.2.2. Large-volume Ultrasonic Nebulizer

    10.3. Market Value Forecast, by Application, 2017–2031

        10.3.1. Chronic Obstructive Pulmonary Disease (COPD)

        10.3.2. Asthma

        10.3.3. Cystic Fibrosis

        10.3.4. Others

    10.4. Market Value Forecast, by End-user, 2017–2031

        10.4.1. Hospitals

        10.4.2. Specialty Clinics

        10.4.3. Others

    10.5. Market Value Forecast, by Country, 2017–2031

        10.5.1. U.S.

        10.5.2. Canada

    10.6. Market Attractiveness Analysis

        10.6.1. By Size

        10.6.2. By Application

        10.6.3. By End-user

        10.6.4. By Country

11. Europe Ultrasonic Nebulizers Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Market Value Forecast, by Size, 2017–2031

        11.2.1. Small-volume Ultrasonic Nebulizer

        11.2.2. Large-volume Ultrasonic Nebulizer

    11.3. Market Value Forecast, by Application, 2017–2031

        11.3.1. Chronic Obstructive Pulmonary Disease (COPD)

        11.3.2. Asthma

        11.3.3. Cystic Fibrosis

        11.3.4. Others

    11.4. Market Value Forecast, by End-user, 2017–2031

        11.4.1. Hospitals

        11.4.2. Specialty Clinics

        11.4.3. Others

    11.5. Market Value Forecast, by Country/Sub-region, 2017–2031

        11.5.1. Germany

        11.5.2. U.K.

        11.5.3. France

        11.5.4. Italy

        11.5.5. Spain

        11.5.6. Rest of Europe

    11.6. Market Attractiveness Analysis

        11.6.1. By Size

        11.6.2. By Application

        11.6.3. By End-user

        11.6.4. By Country/Sub-region

12. Asia Pacific Ultrasonic Nebulizers Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Market Value Forecast, by Size, 2017–2031

        12.2.1. Small-volume Ultrasonic Nebulizer

        12.2.2. Large-volume Ultrasonic Nebulizer

    12.3. Market Value Forecast, by Application, 2017–2031

        12.3.1. Chronic Obstructive Pulmonary Disease (COPD)

        12.3.2. Asthma

        12.3.3. Cystic Fibrosis

        12.3.4. Others

    12.4. Market Value Forecast, by End-user, 2017–2031

        12.4.1. Hospitals

        12.4.2. Specialty Clinics

        12.4.3. Others

    12.5. Market Value Forecast, by Country/Sub-region, 2017–2031

        12.5.1. China

        12.5.2. Japan

        12.5.3. India

        12.5.4. Australia & New Zealand

        12.5.5. Rest of Asia Pacific

    12.6. Market Attractiveness Analysis

        12.6.1. By Size

        12.6.2. By Application

        12.6.3. By End-user

        12.6.4. By Country/Sub-region

13. Latin America Ultrasonic Nebulizers Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Market Value Forecast, by Size, 2017–2031

        13.2.1. Small-volume Ultrasonic Nebulizer

        13.2.2. Large-volume Ultrasonic Nebulizer

    13.3. Market Value Forecast, by Application, 2017–2031

        13.3.1. Chronic Obstructive Pulmonary Disease (COPD)

        13.3.2. Asthma

        13.3.3. Cystic Fibrosis

        13.3.4. Others

    13.4. Market Value Forecast, by End-user, 2017–2031

        13.4.1. Hospitals

        13.4.2. Specialty Clinics

        13.4.3. Others

    13.5. Market Value Forecast, by Country/Sub-region, 2017–2031

        13.5.1. Brazil

        13.5.2. Mexico

        13.5.3. Rest of Latin America

    13.6. Market Attractiveness Analysis

        13.6.1. By Size

        13.6.2. By Application

        13.6.3. By End-user

        13.6.4. By Country/Sub-region

14. Middle East & Africa Ultrasonic Nebulizers Market Analysis and Forecast

    14.1. Introduction

        14.1.1. Key Findings

    14.2. Market Value Forecast, by Size, 2017–2031

        14.2.1. Small-volume Ultrasonic Nebulizer

        14.2.2. Large-volume Ultrasonic Nebulizer

    14.3. Market Value Forecast, by Application, 2017–2031

        14.3.1. Chronic Obstructive Pulmonary Disease (COPD)

        14.3.2. Asthma

        14.3.3. Cystic Fibrosis

        14.3.4. Others

    14.4. Market Value Forecast, by End-user, 2017–2031

        14.4.1. Hospitals

        14.4.2. Specialty Clinics

        14.4.3. Others

    14.5. Market Value Forecast, by Country/Sub-region, 2017–2031

        14.5.1. GCC Countries

        14.5.2. South Africa

        14.5.3. Rest of Middle East & Africa

    14.6. Market Attractiveness Analysis

        14.6.1. By Size

        14.6.2. By Application

        14.6.3. By End-user

        14.6.4. By Country/Sub-region

15. Competition Landscape

    15.1. Market Player - Competition Matrix (by tier and size of companies)

    15.2. Market Share Analysis, by Company, 2021

    15.3. Company Profiles

        15.3.1. Koninklijke Philips N.V

            15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.1.2. Size Portfolio

            15.3.1.3. Financial Overview

            15.3.1.4. SWOT Analysis

            15.3.1.5. Strategic Overview

        15.3.2. OMRON Healthcare, Inc.

            15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.2.2. Size Portfolio

            15.3.2.3. Financial Overview

            15.3.2.4. SWOT Analysis

            15.3.2.5. Strategic Overview

        15.3.3. Drive Medical

            15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.3.2. Size Portfolio

            15.3.3.3. Financial Overview

            15.3.3.4. SWOT Analysis

            15.3.3.5. Strategic Overview

        15.3.4. Invacare Corporation

            15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.4.2. Size Portfolio

            15.3.4.3. Financial Overview

            15.3.4.4. SWOT Analysis

            15.3.4.5. Strategic Overview

        15.3.5. Medline Industries

            15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.5.2. Size Portfolio

            15.3.5.3. Financial Overview

            15.3.5.4. SWOT Analysis

        15.3.6. Agilent Technologies, Inc.

            15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.6.2. Size Portfolio

            15.3.6.3. Financial Overview

            15.3.6.4. SWOT Analysis

        15.3.7. Inspired Medical

            15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.7.2. Size Portfolio

            15.3.7.3. Financial Overview

            15.3.7.4. SWOT Analysis

        15.3.8. Mercury Medical

            15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.8.2. Size Portfolio

            15.3.8.3. Financial Overview

            15.3.8.4. SWOT Analysis

        15.3.9. Besmed

            15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.9.2. Size Portfolio

            15.3.9.3. Financial Overview

        15.3.10. AireHealth

            15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.10.2. Size Portfolio

            15.3.10.3. Financial Overview

            15.3.10.4. SWOT Analysis

List of Tables

Table 01: Global Ultrasonic Nebulizers Market Value (US$ Mn) Forecast, by Size, 2017–2031

Table 02: Global Ultrasonic Nebulizers Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 03: Global Ultrasonic Nebulizers Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 04: Global Ultrasonic Nebulizers Market Value (US$ Mn) Forecast, by Region, 2017–2031

Table 05: North America Ultrasonic Nebulizers Market Value (US$ Mn) Forecast, by Country, 2017–2031

Table 06: North America Ultrasonic Nebulizers Market Value (US$ Mn) Forecast, by Size, 2017–2031

Table 07: North America Ultrasonic Nebulizers Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 08: North America Ultrasonic Nebulizers Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 09: Europe Ultrasonic Nebulizers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 10: Europe Ultrasonic Nebulizers Market Value (US$ Mn) Forecast, by Size, 2017–2031

Table 11: Europe Ultrasonic Nebulizers Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 12: Europe Ultrasonic Nebulizers Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 13: Asia Pacific Ultrasonic Nebulizers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 14: Asia Pacific Ultrasonic Nebulizers Market Value (US$ Mn) Forecast, by Size, 2017–2031

Table 15: Asia Pacific Ultrasonic Nebulizers Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 16: Asia Pacific Ultrasonic Nebulizers Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 17: Latin America Ultrasonic Nebulizers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 18: Latin America Ultrasonic Nebulizers Market Value (US$ Mn) Forecast, by Size, 2017–2031

Table 19: Latin America Ultrasonic Nebulizers Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 20: Latin America Ultrasonic Nebulizers Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 21: Middle East & Africa Ultrasonic Nebulizers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 22: Middle East & Africa Ultrasonic Nebulizers Market Value (US$ Mn) Forecast, by Size, 2017–2031

Table 23: Middle East & Africa Ultrasonic Nebulizers Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 24: Middle East & Africa Ultrasonic Nebulizers Market Value (US$ Mn) Forecast, by End-user, 2017–2031

List of Figures

Figure 01: Global Ultrasonic Nebulizers Market Value (US$ Mn) Forecast, 2017–2031

Figure 02: Global Ultrasonic Nebulizers Market Value Share, by Size (2021)

Figure 03: Global Ultrasonic Nebulizers Market Value Share, by End-user (2021)

Figure 04: Global Ultrasonic Nebulizers Market Value Share, by Application (2021)

Figure 05: Global Ultrasonic Nebulizers Market Value Share, by Region (2021)

Figure 06: Global Ultrasonic Nebulizers Market Value Share Analysis, by Size, 2021 and 2031

Figure 07: Global Ultrasonic Nebulizers Market Attractiveness Analysis, by Size, 2022–2031

Figure 08: Global Ultrasonic Nebulizers Market Value Share Analysis, by Application, 2021 and 2031

Figure 09: Global Ultrasonic Nebulizers Market Attractiveness Analysis, by Application, 2022–2031

Figure 10: Global Ultrasonic Nebulizers Market Value Share Analysis, by End-user, 2021 and 2031

Figure 11: Global Ultrasonic Nebulizers Market Revenue (US$ Mn), by Others, 2017–2031

Figure 12: Global Ultrasonic Nebulizers Market Attractiveness Analysis, by End-user, 2022–2031

Figure 13: Global Ultrasonic Nebulizers Market Value Share Analysis, by Region, 2021 and 2031

Figure 14: Global Ultrasonic Nebulizers Market Attractiveness Analysis, by Region, 2022-2031

Figure 15: North America Ultrasonic Nebulizers Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 16: North America Ultrasonic Nebulizers Market Value Share (%), by Country, 2021 and 2031

Figure 17: North America Ultrasonic Nebulizers Market Attractiveness Analysis, by Country, 2022–2031

Figure 18: North America Ultrasonic Nebulizers Market Value Share Analysis, by Size, 2021 and 2031

Figure 19: North America Ultrasonic Nebulizers Market Attractiveness Analysis, by Size, 2022–2031

Figure 20: North America Ultrasonic Nebulizers Market Value Share Analysis, by Application, 2021 and 2031

Figure 21: North America Ultrasonic Nebulizers Market Attractiveness Analysis, by Application, 2022–2031

Figure 22: North America Ultrasonic Nebulizers Market Value Share Analysis, by End-user, 2021 and 2031

Figure 23: North America Ultrasonic Nebulizers Market Attractiveness Analysis, by End-user, 2022–2031

Figure 24: Europe Ultrasonic Nebulizers Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 25: Europe Ultrasonic Nebulizers Market Value Share (%), by Country/Sub-region, 2021 and 2031

Figure 26: Europe Ultrasonic Nebulizers Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

Figure 27: Europe Ultrasonic Nebulizers Market Value Share Analysis, by Size, 2021 and 2031

Figure 28: Europe Ultrasonic Nebulizers Market Attractiveness Analysis, by Size, 2022–2031

Figure 29: Europe Ultrasonic Nebulizers Market Value Share Analysis, by Application, 2021 and 2031

Figure 30: Europe Ultrasonic Nebulizers Market Attractiveness Analysis, by Application, 2022–2031

Figure 31: Europe Ultrasonic Nebulizers Market Value Share Analysis, by End-user, 2021 and 2031

Figure 32: Europe Ultrasonic Nebulizers Market Attractiveness Analysis, by End-user, 2022–2031

Figure 33: Asia Pacific Ultrasonic Nebulizers Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 34: Asia Pacific Ultrasonic Nebulizers Market Value Share (%), by Country/Sub-region, 2021 and 2031

Figure 35: Asia Pacific Ultrasonic Nebulizers Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

Figure 36: Asia Pacific Ultrasonic Nebulizers Market Value Share Analysis, by Size, 2021 and 2031

Figure 37: Asia Pacific Ultrasonic Nebulizers Market Attractiveness Analysis, by Size, 2022–2031

Figure 38: Asia Pacific Ultrasonic Nebulizers Market Value Share Analysis, by Application, 2021 and 2031

Figure 39: Asia Pacific Ultrasonic Nebulizers Market Attractiveness Analysis, by Application, 2022–2031

Figure 40: Asia Pacific Ultrasonic Nebulizers Market Value Share Analysis, by End-user, 2021 and 2031

Figure 41: Asia Pacific Ultrasonic Nebulizers Market Attractiveness Analysis, by End-user, 2022–2031

Figure 42: Latin America Ultrasonic Nebulizers Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 43: Latin America Ultrasonic Nebulizers Market Value Share (%), by Country/Sub-region, 2021 and 2031 

Figure 44: Latin America Ultrasonic Nebulizers Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

Figure 45: Latin America Ultrasonic Nebulizers Market Value Share Analysis, by Size, 2021 and 2031 

Figure 46: Latin America Ultrasonic Nebulizers Market Attractiveness Analysis, by Size, 2022–2031

Figure 47: Latin America Ultrasonic Nebulizers Market Value Share Analysis, by Application, 2021 and 2031 

Figure 48: Latin America Ultrasonic Nebulizers Market Attractiveness Analysis, by Application, 2022–2031

Figure 49: Latin America Ultrasonic Nebulizers Market Value Share Analysis, by End-user, 2021 and 2031

Figure 50: Latin America Ultrasonic Nebulizers Market Attractiveness Analysis, by End-user, 2022–2031

Figure 51: Middle East & Africa Ultrasonic Nebulizers Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 52: Middle East & Africa Ultrasonic Nebulizers Market Value Share (%), by Country/Sub-region, 2021 and 2031

Figure 53: Middle East & Africa Ultrasonic Nebulizers Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

Figure 54: Middle East & Africa Ultrasonic Nebulizers Market Value Share Analysis, by Size, 2021 and 2031

Figure 55: Middle East & Africa Ultrasonic Nebulizers Market Attractiveness Analysis, by Size, 2022–2031

Figure 56: Middle East & Africa Ultrasonic Nebulizers Market Value Share Analysis, by Application, 2021 and 2031

Figure 57: Middle East & Africa Ultrasonic Nebulizers Market Attractiveness Analysis, by Application, 2022–2031

Figure 58: Middle East & Africa Ultrasonic Nebulizers Market Value Share Analysis, by End-user, 2021 and 2031

Figure 59: Middle East & Africa Ultrasonic Nebulizers Market Attractiveness Analysis, by End-user, 2022–2031

Figure 60: Global Ultrasonic Nebulizers Market Share Analysis, by Company, 2021

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

488

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved